Marshall Wace’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.1K | Buy |
+9,079
| New | +$68.1K | ﹤0.01% | 2428 |
|
|
2025
Q1 | – | Sell |
-624
| Closed | -$22.3K | – | 2739 |
|
|
2024
Q4 | $22.3K | Buy |
+624
| New | +$22.3K | ﹤0.01% | 2325 |
|
|
2024
Q3 | – | Sell |
-7,041
| Closed | -$354K | – | 2591 |
|
|
2024
Q2 | $354K | Buy |
7,041
+5,504
| +358% | +$277K | ﹤0.01% | 1906 |
|
|
2024
Q1 | $172K | Sell |
1,537
-4,775
| -76% | -$535K | ﹤0.01% | 1980 |
|
|
2023
Q4 | $366K | Hold |
6,312
| – | – | ﹤0.01% | 1534 |
|
|
2023
Q3 | $200K | Sell |
6,312
-102,140
| -94% | -$3.24M | ﹤0.01% | 1668 |
|
|
2023
Q2 | $8.92M | Buy |
108,452
+8,584
| +9% | +$706K | 0.02% | 682 |
|
|
2023
Q1 | $10.3M | Sell |
99,868
-1,091
| -1% | -$112K | 0.02% | 609 |
|
|
2022
Q4 | $14.8M | Buy |
100,959
+79,820
| +378% | +$11.7M | 0.03% | 524 |
|
|
2022
Q3 | $3.57M | Buy |
+21,139
| New | +$3.57M | 0.01% | 1321 |
|
|
2022
Q2 | – | Sell |
-1,307
| Closed | -$130K | – | 2990 |
|
|
2022
Q1 | $130K | Buy |
+1,307
| New | +$130K | ﹤0.01% | 2447 |
|
|
2021
Q4 | – | Sell |
-15,389
| Closed | -$3.63M | – | 3433 |
|
|
2021
Q3 | $3.63M | Buy |
15,389
+14,595
| +1,838% | +$3.44M | 0.02% | 964 |
|
|
2021
Q2 | $269K | Sell |
794
-5,290
| -87% | -$1.79M | ﹤0.01% | 1864 |
|
|
2021
Q1 | $2.46M | Buy |
6,084
+2,120
| +53% | +$858K | 0.01% | 1055 |
|
|
2020
Q4 | $2.64M | Buy |
+3,964
| New | +$2.64M | 0.01% | 758 |
|
|
2019
Q4 | – | Sell |
-4,862
| Closed | -$192K | – | 1883 |
|
|
2019
Q3 | $192K | Sell |
4,862
-2,033
| -29% | -$80.3K | ﹤0.01% | 1246 |
|
|
2019
Q2 | $698K | Buy |
6,895
+5,825
| +544% | +$590K | 0.01% | 985 |
|
|
2019
Q1 | $141K | Buy |
+1,070
| New | +$141K | ﹤0.01% | 1377 |
|